Warby Parker (WRBY) Competitors $24.29 +0.11 (+0.45%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends WRBY vs. PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, NVST, NARI, and IRTCShould you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. Warby Parker vs. Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both mid-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, community ranking, risk, earnings, media sentiment, institutional ownership and dividends. Which has more risk & volatility, WRBY or PEN? Warby Parker has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Do analysts prefer WRBY or PEN? Warby Parker currently has a consensus target price of $20.73, suggesting a potential downside of 14.67%. Penumbra has a consensus target price of $254.15, suggesting a potential upside of 2.68%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.67Penumbra 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80 Is WRBY or PEN more profitable? Penumbra has a net margin of 2.97% compared to Warby Parker's net margin of -4.39%. Penumbra's return on equity of 8.99% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-4.39% -8.26% -4.37% Penumbra 2.97%8.99%6.80% Does the MarketBeat Community prefer WRBY or PEN? Penumbra received 779 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 80.27% of users gave Penumbra an outperform vote while only 42.86% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformWarby ParkerOutperform Votes3942.86% Underperform Votes5257.14% PenumbraOutperform Votes81880.27% Underperform Votes20119.73% Do institutionals and insiders believe in WRBY or PEN? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 26.5% of Warby Parker shares are owned by company insiders. Comparatively, 5.0% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor WRBY or PEN? In the previous week, Warby Parker and Warby Parker both had 20 articles in the media. Penumbra's average media sentiment score of 0.81 beat Warby Parker's score of 0.61 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 8 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 8 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Which has higher valuation and earnings, WRBY or PEN? Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$742.53M3.33-$63.20M-$0.27-89.96Penumbra$1.16B8.16$90.95M$0.86287.80 SummaryPenumbra beats Warby Parker on 15 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Warby Parker News Delivered to You Automatically Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WRBY vs. The Competition Export to ExcelMetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE ExchangeMarket Cap$2.46B$11.21B$14.53B$19.67BDividend YieldN/A1.63%2.65%3.51%P/E Ratio-89.9641.8022.9843.79Price / Sales3.335.292.7817.64Price / CashN/A16.6921.1421.73Price / Book7.893.425.975.46Net Income-$63.20M$235.23M$580.19M$987.68M7 Day Performance3.23%-0.44%-1.44%-2.32%1 Month Performance6.44%-3.82%1.81%0.63%1 Year Performance105.50%5.70%6.04%16.39% Warby Parker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WRBYWarby Parker1.6879 of 5 stars$24.29+0.5%$20.73-14.7%+106.2%$2.46B$742.53M-89.963,491Analyst ForecastPENPenumbra4.2025 of 5 stars$247.98+1.0%$252.42+1.8%+0.8%$9.52B$1.16B285.524,200Analyst ForecastGKOSGlaukos4.1648 of 5 stars$143.91+3.6%$143.17-0.5%+79.6%$7.93B$360.35M-46.00780Short Interest ↓BLCOBausch + Lomb2.2616 of 5 stars$18.58-0.1%$20.58+10.8%+24.3%$6.54B$4.68B-17.7113,300Short Interest ↑INSPInspire Medical Systems4.6937 of 5 stars$188.20+0.2%$233.58+24.1%+1.4%$5.64B$755.59M176.781,011Short Interest ↓Positive NewsPRCTPROCEPT BioRobotics3.0564 of 5 stars$89.44+0.2%$97.86+9.4%+104.0%$4.67B$136.19M0.00626Positive NewsAXNXAxonics1.1641 of 5 stars$70.98+0.8%$71.00+0.0%+21.8%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.87 of 5 stars$32.84-1.7%$32.67-0.5%+136.7%$3.55B$577.74M-23.861,453NVSTEnvista3.621 of 5 stars$19.52+0.3%$20.65+5.8%-19.3%$3.36B$2.50B-2.5112,800Positive NewsNARIInari Medical2.544 of 5 stars$55.46-0.2%$58.89+6.2%-13.5%$3.25B$574.50M-41.181,300Analyst ForecastIRTCiRhythm Technologies3.0394 of 5 stars$89.29+3.3%$107.82+20.8%-9.5%$2.79B$492.68M-17.782,000 Related Companies and Tools Related Companies PEN Competitors GKOS Competitors BLCO Competitors INSP Competitors PRCT Competitors AXNX Competitors NVCR Competitors NVST Competitors NARI Competitors IRTC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:WRBY) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Warby Parker Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Warby Parker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.